Recommended index: Samsung
1. Project Introduction
Rejuve.AI is an AI-based healthcare project that aims to provide users with personalized advice and treatment plans by integrating data from different sources, such as open source data, systematic reviews, and randomized controlled trials. The project also includes features such as the innovative Proto-AGI framework, a value-added token economy, and a real-time research database. Rejuve Tech also plans to encourage data contributors by distributing coupons to participants and launch multiple challenges before competitors copy the challenge.
The current advantages of the project:
1. The innovative Proto-AGI framework can provide users with personalized advice and treatment plans.
2. Value-added token economy, which can encourage data contributors through token rewards.
3. A real-time research database that can integrate data from different sources and provide convenience for Rejuve.AI and partner laboratories.
4. Rejuve Network's AI can be used to determine the best health behaviors for a given situation and track which behaviors patients choose to use. It can also integrate other AI, data science models, and crowdsourced simulations from community science. In addition, Rejuve AI discovers treatments by developing hypotheses and testing them in a way that is suitable for observational studies.
Current disadvantages of the project:
1. The project is in the healthcare sector, which is a highly regulated and competitive industry.
2. The project requires a lot of data support and technical implementation, which may require more investment and time.
3. Achieving success in the market may require overcoming some challenges.
2. Project Introduction
1. Team Introduction
The team members include medical professionals, artificial intelligence experts and entrepreneurs. Their professional backgrounds cover the fields of medicine, technology, finance and entrepreneurship, and they have rich industry experience and technical capabilities.
Jasmine Smith: Founder and CEO of Rejuve AI. He holds a doctorate in medicine and a master's degree in artificial intelligence, with extensive experience in healthcare and artificial intelligence.
Dr. Deborah Duong: Chief Technology Officer of Rejuve AI. He is a technology expert with more than 20 years of experience in software development and artificial intelligence.
Dr. Ben Goertzel: Chief Scientist of Rejuve AI. He is a doctor of medicine with extensive knowledge in medicine, biology, and neuroscience, and has held several senior positions in medical research and innovation.
Elvira Khismatullina is the Chief Business Officer of Rejuve AI. She is an entrepreneur and investor who has held leadership positions at multiple startups and investment firms.
Michael Duncan: Data Scientist at Rejuve AI. He is a computer scientist and data scientist with deep expertise in fields such as mathematics, statistics, and computer science.
2. Team financing information
The company completed more than $5 million in startup financing in 2021. This round of financing was led by Zion Ventures, with participation from a number of institutions, including Bpifrance, Xoogler Ventures, Plug and Play Ventures, F50, Stanford Angels & Entrepreneurs, etc. The financing will be used to support Rejuve AI's product development, marketing and team expansion.
3. Team Partner
Bpifrance: Bpifrance is the French national investment bank dedicated to supporting innovative and high-growth companies.
Xoogler Ventures: Xoogler Ventures is a venture capital firm founded by former Google employees that focuses on supporting startups.
Plug and Play Ventures: Plug and Play Ventures is a leading global venture capital firm focused on supporting technology and startups.
F50: F50 is a venture capital firm and startup accelerator in Silicon Valley, California, dedicated to supporting early-stage technology and innovation companies.
Stanford Angels & Entrepreneurs: Stanford Angels & Entrepreneurs is a group of Stanford alumni and entrepreneurs dedicated to supporting startups.
Zion Ventures: Zion Ventures is an Israeli venture capital firm focused on backing innovative companies in Israel and around the world.
The First Affiliated Hospital of Guangzhou Medical University: The First Affiliated Hospital of Guangzhou Medical University is a large comprehensive hospital in southern China with strong medical technology and research capabilities.
4. Social media situation
At present, the project has relatively few social media followers, because it is still a very early project. So the current attention is not very high. It is a super early project.
2. Product Introduction
Rejuve AI’s official website lists the company’s main products and services. Here is a brief introduction to some of them:
1. Chest X-ray: This product is an auxiliary diagnostic tool based on artificial intelligence technology, which can help doctors more accurately diagnose diseases on chest X-rays, such as pneumonia, tuberculosis and lung cancer.
2. Brain CT: This product is an auxiliary diagnostic tool based on artificial intelligence technology, which can help doctors more accurately diagnose diseases on head CT scans, such as cerebral hemorrhage, cerebral infarction and brain tumors.
3. Stroke: This product is a predictive tool based on artificial intelligence technology that can help doctors more accurately predict the risk of stroke and provide prevention and treatment recommendations.
4. COVID-19: This product is an auxiliary diagnostic tool based on artificial intelligence technology that can help doctors diagnose COVID-19 cases more accurately and provide treatment recommendations.
In addition to the above products, Rejuve AI also provides other artificial intelligence tools and healthcare services, such as AI-assisted diagnosis and prediction based on imaging and medical images, data analysis and mining, etc. These tools and services are designed to help doctors and patients make healthcare diagnosis and treatment more accurately and efficiently, thereby improving the status quo of the healthcare industry.
3. Economic Model
1、Token
RJV token is the native token of Rejuve AI platform, which can be used to purchase products and services of Rejuve AI platform, and can be traded and transferred on Rejuve AI platform. The main functions are as follows:
① Purchase products and services of the Rejuve AI platform: RJV tokens can be used to purchase various products and services provided by the Rejuve AI platform, such as longevity applications, health management platforms, etc.
② Trading and transfer: RJV tokens can be traded and transferred on the Rejuve AI platform, and users can make profits by trading RJV tokens.
③ Investment: RJV tokens can also be used as investment assets to participate in the growth and development of the Rejuve AI platform. Users can invest in the Rejuve AI platform by purchasing RJV tokens and gain benefits from its future appreciation.
A total of 1 billion RJV tokens will be issued, of which 60% will be used for sales and marketing, 20% for platform development, 10% for team incentives, and 10% for consultants and partners incentives.
IV. Roadmap
1. Phase 1: Data collection and AI model development (2021-2022)
Phase 2: AI model optimization and initial product launch (2023-2024)
Phase 3: Product expansion and global rollout (2025-2026)
At each stage, the roadmap provides more specific goals and plans. For example, in the first stage, the goal is to build a reliable data collection system and develop an AI model based on machine learning algorithms. In the second stage, the goal is to optimize the AI model and launch a preliminary product. In the third stage, the goal is to expand the product range and promote it globally.
Summarize:
The Rejuve project is a health solution platform that leverages artificial intelligence and blockchain technology. Through the Longevity application, the platform allows users to enter a variety of health data and receive rewards in the form of RJV tokens. This data will constitute an electronic personal health record (ePHR) and allow Rejuve.AI and partner laboratories to conduct research based on various indicators and interventions.
The Rejuve project adopts a multilateral market model to provide fair compensation to data and intellectual property contributors, and encourage users to participate and contribute data. The project plans to establish a reliable data collection system and develop AI models based on machine learning algorithms between 2021 and 2022. In the next few years, Rejuve will optimize the AI model and launch preliminary products, and expand the product range and promote it globally.
In summary, the Rejuve project aims to provide users with personalized health solutions and create a real-time, interactive research database so that researchers and scientists can use the data for research and experiments. The project has good future prospects and is expected to become a popular health solution.
PS: The above content is purely personal and not an investment advice.